The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Development of Progressive Pre-clinical Models of PD, 2006The PD Pre-Clinical Model: A Progressive Model of Parkinson's Disease with Key Pathology and Behavior Caused by Targeting Mitochondrial Function in Dopamine Neurons
Recent research suggests that there can be genetic causes of Parkinson's disease. In several forms of the disease, these genetic disturbances appear to compromise function of the cells' energy...
-
Development of Progressive Pre-clinical Models of PD, 2006Rat Transgenic Models for Autosomal Dominant PD via BAC Technology
Animal models are crucial in the mechanistic study of Parkinson's disease and therapeutic development. However, a severe and unfortunate roadblock is that to date no genetic mammalian models have...
-
Development of Progressive Pre-clinical Models of PD, 2006Two-Hit Pre-clinical Models for Parkinson’s Disease
Despite recent advances in Parkinson's disease genetics, the animal models based on identified genetic defects have not largely emulated the progressive nigral neuron degeneration that characterizes...
-
Target Validation, 2006Granulocyte-colony Stimulating Factor (G-CSF) as a Neuroprotective Therapy for Parkinson's Disease
Although a relatively large number of drugs is available to alleviate the symptoms of Parkinson's disease, there is no therapy available so far that halts or delays the disease progression. This...
-
Target Validation, 2006Cell-specific Lentiviral Vectors to Target and Normalize GAD 67 Expression in enkephalinergic striatal out-put neurons in experimental Parkinson's Disease
In Parkinson's disease, neurons of the striatum become dysregulated. Therefore signals are not processed correctly and as a consequence the symptoms of PD arise. Lentiviral vectors transduce both...
-
Target Validation, 2006High-throughput Screen for Small Molecule LRRK2 Inhibitors
The last decade of Parkinson's disease research heralded the discovery of specific genes mutated in rare familial disease cases. Investigating these rare gene mutations has provided a heightened...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.